title: Interleukin-15 strongly inhibits interleukin-8 and monocyte chemoattractant protein-1 production in human colonic epithelial cells.
abstract: Interleukin-15 (IL-15) is a novel cytokine with actions similar to IL-2 because of common receptor components. Although IL-15 is expressed in colonic epithelial cells and may regulate epithelial cell function, its effects on these cells are not fully defined. We explored the regulatory effects of IL-15 on IL-8 and monocyte-chemoattractant protein-1 (MCP-1) production in the colonic epithelial cell line Caco-2 as well as in freshly isolated human colonic epithelial cells. IL-15 was added to intestinal epithelial cells under various culture conditions. Levels of chemokines were determined by enzyme-linked immunosorbent assay. To determine the elements of the IL-2/IL-15R complex involved we used neutralizing antibodies specific for individual receptor chains. IL-15 down-regulates IL-8 and MCP-1 production in Caco-2 cells as well as in freshly isolated human colonic epithelial cells in a dose-dependent manner. Intestinal epithelial cells became more responsive to IL-15-induced suppression when activated with greater IL-1 doses. Strong chemokine suppression was seen when IL-15 was given prior to, simultaneous with, or after stimulatory agent. Anti-IL-2Rgamma antibodies efficiently blocked (82% inhibition) the suppression induced by IL-15, while anti-IL-2Rbeta antibodies were less effective. The involvement of beta-chain was further suggested by the finding that a mixture of both monoclonal antibodies (mAb) at a suboptimal concentration (1 microgram/ml of each mAb) produced a synergistic inhibitory effect on down-regulation of epithelial chemokine production. These results show that IL-15 can suppress IL-8 and MCP-1 secretion by intestinal epithelial cells. A microenvironment containing high concentrations of IL-15 may alter the recruitment of neutrophils to enterocytes at least partly by inhibiting IL-8 and MCP-1 production.
authors.affiliation: Department of Medicine B, University of Münster, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Lügering
authors.forename: T
authors.initials: T
authors.lastname: Kucharzik
authors.forename: C
authors.initials: C
authors.lastname: Maaser
authors.forename: M
authors.initials: M
authors.lastname: Kraft
authors.forename: W
authors.initials: W
authors.lastname: Domschke
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology; D018938:Caco-2 Cells; D002478:Cells, Cultured; D018932:Chemokine CCL2 / Q000378:metabolism*; D003106:Colon / Q000276:immunology*; D003864:Depression, Chemical; D004306:Dose-Response Relationship, Immunologic; D004848:Epithelium / Q000276:immunology; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D019409:Interleukin-15 / Q000494:pharmacology*; D016209:Interleukin-8 / Q000378:metabolism*; D053647:Receptors, Interleukin-15; D015375:Receptors, Interleukin-2 / Q000276:immunology; D011994:Recombinant Proteins / Q000494:pharmacology
chemical_list: D000911:Antibodies, Monoclonal; D018932:Chemokine CCL2; C508024:IL15RA protein, human; D007375:Interleukin-1; D019409:Interleukin-15; D016209:Interleukin-8; D053647:Receptors, Interleukin-15; D015375:Receptors, Interleukin-2; D011994:Recombinant Proteins